Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Phase 4 Completed 50 enrolled University of Florida

RandomizedParallel-groupOpen-labelTreatment

Summary

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the sphenopalatine ganglion using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

Timeline

Start: 2023-04-12
Primary completion: 2025-02-28
Completion: 2025-02-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ropivacaine	Other / unclassified	20 mg	Other
Background	Dexamethasone	Small molecule	4 mg	Other

Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Summary

Timeline

Drugs

Indications